Skip to main content
Retour
TYRA logo

Tyra Biosciences, Inc.

Qualité des données : 100%
TYRA
NASDAQ Healthcare Biotechnology
36,52 €
▼ 0,63 € (-1,70%)
Cap. Boursière : 1,96B
Fourchette du Jour
34,85 € 38,91 €
Fourchette 52 Semaines
6,42 € 39,15 €
Volume
959 958
Moyenne 50J / 200J
32,17 € / 19,01 €
Clôture Précédente
37,15 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -16,4 0,4
P/B 7,6 2,9
ROE % -39,8 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Points Clés

Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -95,28M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-39,83%
ROIC-37,58%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,02
Current Ratio14,67
Interest Coverage0,00

Valorisation

P/E Ratio
-16,35
P/B Ratio7,57
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -119,95M
ROE -39,83% ROA -42,44%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -95,28M
ROIC -37,58% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,02 Current Ratio 14,67
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio -16,35 P/B Ratio 7,57
P/S Ratio N/A PEG Ratio -0,39
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 1,96B Enterprise Value 1,89B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -119,95M -86,48M -69,13M -55,33M -26,29M
EPS (Diluted) -2,01 -1,51 -1,62 -1,23 -0,63
Gross Profit -546 000,0 0,0 0,0 0,0 0,0
Operating Income -132,76M -104,18M -79,95M -58,93M -26,29M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 282,61M 363,56M 225,86M 266,18M 306,70M
Total Liabilities 23,43M 20,41M 21,60M 8,35M 4,96M
Shareholders' Equity 259,18M 343,15M 204,26M 257,83M 301,74M
Total Debt 5,81M 6,22M 6,50M 2,62M 1,18M
Cash & Equivalents 77,39M 91,97M 58,01M 251,21M 302,18M
Current Assets 265,45M 347,46M 211,67M 257,29M 304,06M
Current Liabilities 18,09M 14,59M 15,33M 5,70M 3,62M